PulseAI Receives U.S. FDA 510(k) Clearance of AI-Powered Arrhythmia Analysis Model for Wearables
Published study reports PulseAI model delivers up to 10x performance improvement when used with leading wearables BELFAST, Northern Ireland, Nov. 5, 2026 — PulseAI, a medical technology company developing artificial intelligence for cardiac diagnostics, today…











